pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Heidi Overton, Trump’s FDA nominee, to appear before Senate committee for confirmation hearing

Sep 24, 2026·read at STAT ↗RegulatoryNeutral

Heidi Overton, a 37‑year‑old preventive‑medicine physician, is the Trump administration’s pick to lead the Food and Drug Administration and will face a Senate committee this morning.

Lawmakers have expressed concerns about her limited managerial experience and her support for policies advanced by Health Secretary Robert F. Kennedy Jr., including proposals to alter the childhood vaccine schedule.

If confirmed, Overton would become the youngest FDA commissioner ever, taking charge of an agency that has endured a turbulent 18 months marked by politicized decisions and a nearly 20 percent staff reduction.

The hearing is expected to probe how she plans to restore the agency’s scientific workforce and navigate ongoing regulatory challenges.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Heidi Overton, Trump’s pick for FDA head, to face questions at Senate hearing”

read at STAT ↗
425 words · retrieved 47m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Vaccine2Vaccines

related stories

  • May 8Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbookSTAT
  • May 6STAT+: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy fieldSTAT
  • May 4Federal court blocks mailing of mifepristoneSTAT
  • May 2Opinion: What do medical students think about their education?STAT
  • May 1Moderna in talks with FDA over Phase 4 Covid vaccine dataEndpoints